2-Tirgary F, Jahanzad I, Yazdani F. Neuroendocrine carcinoma tumors of immunohistochemistry department of “Cancer institute” in 1996-2000. Tehran University Medical Journal (TUMJ) 2003; 61(2): 90-94.
3-Klimstra DS, Modlin IR, Coppola D et al. The pathologic classification of neuroendocrine tumors: A review of nomenclature, grading, and staging systems. Pancreas 2010; 39: 707–712 .
4-Sadighi S, Roshanaee GH,Vahedi S, Jahanzad E, MohagheghiMA, Jarahi A. Neuroendocrine tumors in Iran Cancer Institute: Predictive factors of patient survival. Asian Pac J Cancer 2014;15:7835-8.
5-Alsina, Maria; Marcos-Gragera, Rafa ; et al el .Neuroendocrine tumors: A population-based study of incidence and survival in Girona province, 1994-2004. Cancer Epidemiology 35.6 (2011): e49-54 .
6-Alsina M, Marcos-Gragera R, Capdevila J, Buxó M, Ortiz RM, Barretina P, et al. Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994–2004. Cancer epidemiology. 2011;35(6):e49-e54.
9-Koji Ikeda ,Motohiro Kojima, Norio Saito et al. Current status of the histopathological assessment, diagnosis, and reporting of colorectal neuroendocrine tumors: A Web survey from the Japanese Society for Cancer of Colon and Rectum .international pathology 2016 ; 66(2) : 94-101.